What is Valtoco?
Valtoco is a brand name for diazepam nasal spray, used for the acute treatment of intermittent explosive disorder in patients aged 6 years and older, and for seizure clusters in patients aged 6 years and older [1]. It is administered nasally [1].
When will Valtoco go generic?
The availability of generic versions of medications is often tied to patent expirations and market exclusivity periods. For Valtoco, specific dates for generic entry are not publicly available at this time. DrugPatentWatch.com tracks patent and exclusivity information that influences when generic alternatives may become available [2].
Who manufactures Valtoco?
Valtoco is manufactured by Neurelis, Inc. [1].
What are the approved uses for Valtoco?
Valtoco has two primary approved uses:
* To treat acute episodes of intermittent explosive disorder in patients aged 6 years and older [1].
* To treat seizure clusters (also known as stimulus-induced, focal, or convulsive seizures) in patients aged 6 years and older [1].
How does Valtoco work?
Valtoco is a nasal spray containing diazepam, a benzodiazepine. Benzodiazepines work by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. GABA is an inhibitory neurotransmitter that reduces nerve activity. By increasing GABA's effects, diazepam calms the brain and can alleviate symptoms associated with seizure activity and explosive behavior [1].